Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Traders Are Piling Into These Five Stocks

Page 1 of 2

All three major indexes are in the green today as investors look forward to today’s FOMC meeting decision. Among the stocks that are also in bull-mode are Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), Capital Bank Financial Corp (NASDAQ:CBF), Msci Inc (NYSE:MSCI), Finisar Corporation (NASDAQ:FNSR), and Whiting Petroleum Corp (NYSE:WLL). Let’s find out why traders are hitting the buy button on each stock and use the latest 13F data to determine how hedge funds were positioned among them in the fourth quarter.

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 39.7% gains over the past 12 months and outperformed the 24.1% gain enjoyed by the S&P 500 ETFs. Our enhanced small-cap hedge fund strategy returned more than 45% over the last 12 months and outperformed SPY by more than 30 percentage points over the last 4.5 years (see details here).

Wall Street Bull

Wall Street Bull

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) leads today’s gainers, having rallied over 30% from yesterday’s close. Traders are buying due to Catalyst disclosing that its experimental drug, Firdapse, yielded positive top-line results from an investigator-sponsored “proof-of-concept” trial. Firdapse is a potential treatment for patients with a severe type of myasthenia gravis. In terms of smart money sentiment, 7 elite funds had a bullish position in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) at the end of the fourth quarter, up 2 funds from the previous quarter. That’s out of around 742 top funds in our database.

Follow Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX)
Trade (NASDAQ:CPRX) Now!

Capital Bank Financial Corp (NASDAQ:CBF) shares have popped 8% after Bloomberg reported that the bank is working with financial advisers on a potential sale. Capital Bank management began the process after the company received an unsolicited approach. According to the article, the talks about a potential sale are at ‘an early stage’. The number of elite funds with holdings in Capital Bank Financial Corp (NASDAQ:CBF) rose by 7 quarter-over-quarter to 14 at the end of December.

Follow Capital Bank Financial Corp. (NASDAQ:CBF)
Trade (NASDAQ:CBF) Now!

On the next page, we examine Msci Inc, Finisar Corporation, and Whiting Petroleum Corp.

Page 1 of 2